Abstract

## Background

Cigarette smoke contains free radicals and an have adverse effect to the
immune system. Supplementation of palm oil vitamin E (palmvitee), is
known has antioxidant properties is thought to be beneficial for system
immune protection against free radicals activity. The objective of the
study was to determine the effect of palmvitee supplementation on immune
response in smokers.

## Methods

This study involved a group of smokers and nonsmokers who received
200 mg/day palmvitee and placebo for the control group. Blood samples
were taken at 0, 12 and 24 weeks of supplementation. Plasma tocopherol
and tocotrienol were determined by HPLC, lymphocyte proliferation by
lymphocyte transformation test (LTT) and enumeration of lymphocytes T
and B cells by flow cytometry. Statistical analysis was performed by
Mann--Whitney *U*-test for non-parametric data distribution and
correlation among the variables was examined by Spearman.

## Results

Plasma tocopherol and tocotrienol were increased in vitamin E
supplemented group as compared to placebo group. Urine cotinine levels
and serum α~1~-antitrypsin were significantly higher in smokers compared
to nonsmokers. Lymphocyte proliferation induced by PHA showed an
increasing trend with palmvitee supplementation in both smokers and
nonsmokers. Natural killer cells were decreased; CD4^+^ cells and B
cells were increased in smokers compared to nonsmokers but were
unaffected with vitamin E supplementation except in the percentage of B
cells which were increased in nonsmokers supplemented palmvitee compared
to placebo. CD4^+^/CD8^+^ ratio was increased in smokers compared to
nonsmokers. The high TWBC count observed in smokers correlated with the
increased CD4^+^ and B cells.

## Conclusions

Smoking caused alterations in certain immune parameters and palmvitee
supplementation tended to cause an increase in lymphocytes
transformation test but had no effect on CD3^+^, CD4^+^, CD8^+^, NK
cells and B cells except B cells percentage in nonsmokers.

# Results

## Plasma total vitamin E level

There was no difference in total plasma vitamin E, tocopherol and
tocotrienol levels in smokers and nonsmokers at the beginning of the
study (Figure  [1](#) & Table  [1](#)). After palmvitee supplementation,
both plasma tocopherol and tocotrienol concentration were increased in
smokers and nonsmokers (p \< 0.05) starting from 12 weeks until the end
of the experiment. Tocopherol concentration was higher in plasma as
compared to tocotrienol. Urinary cotinine and serum α~1~-antitrypsin of
smokers were significantly higher (p \< 0.05) compared to nonsmokers
(Table  [1](#)) but no changes were observed with supplementation.
Urinary cotinine levels were increased accordingly to the number of
cigarettes per day (Table  [2](#)).

<figure>
<p><img src="" /></p>
<figcaption>Total plasma vitamin E concentration in smokers and
nonsmokers.</figcaption>
</figure>

:::: table-wrap
::: caption
**The effects of palmvitee supplementation on plasma tocopherol and
tocotrienol,** α~**1**~**-antitrypsin in serum and urine cotinine levels
in smokers and nonsmokers**
:::

  **Weeks**   **Tocopherol (μg/ml plasma)**                                                               
  ----------- ------------------------------- ----------------------------------------- ----------------- --------------------
              **Nonsmokers**                  **Smokers**                                                 
              Placebo, n = 27                 Palmvitee, n = 29                         Placebo, n = 28   Palmvitee,n = 30
  0           11.67 ± 3.19                    11.75 ± 2.27                              11.58 ± 3.19      11.39 ± 3.06
  12          10.42 ± 2.17                    14.22 ± 3.61\*                            10.27 ± 3.33      13.92 ± 4.17\*\*
  24          11.52 ± 2.94                    14.56 ± 3.06\*                            11.53 ± 2.78      14.11 ± 3.89\*\*
                                              **Tocotrienol (ng/ml)**                                     
  0           62.49 ± 6.69                    63.60 ± 5.67                              60.05 ± 6.39      59.49 ± 4.21
  12          63.50 ± 7.87                    656.25 ± 142.50\*                         61.27 ± 3.62      570.22 ± 98.64\*\*
  24          60.65 ± 7.13                    675.16 ± 150.00\*                         60.47 ± 3.00      587.68 ± 87.50\*\*
                                              **CCR, (μg/mg creatinine)**                                 
              n = 16                          n = 19                                    n = 21            n = 20
  0           0.052 ± 0.017                   0.046 ± 0.017                             0.927 ± 0.734#    0.941 ± 0.700#
  24          0.058 ± 0.030                   0.047 ± 0.017                             0.866 ± 0.754#    1.179 ± 0.738#
                                              **α**~**1**~**-antitripsin(g/L serum)**                     
              n = 16                          n = 19                                    n = 28            n = 30
  0           1.48 ± 0.31                     1.49 ± 0.34                               1.99 ± 0.43#      1.94 ± 0.31#
  24          1.47 ± 0.20                     1.45 ± 0.24                               1.69 ± 0.37       1.75 ± 0.39

Results are shown as mean ± SD. \* indicates significant difference as
compared to nonsmokers taking placebo (p \< 0.01), \*\* indicates
significant difference as compared to smokers taking placebo
(p \< 0.01), \# indicates significant difference as compared to
nonsmokers (p \< 0.0001), CCR represents cotinine:creatinine ratio.
::::

:::: table-wrap
::: caption
Baseline levels of lymphocytes in nonsmokers and smokers according to
the number of cigarettes per day
:::

                                        **Nonsmokers n = 56**   **S1 (n = 7)**    **S2 (n = 34)**   **S3 (n = 15)**
  ------------------ ------------------ ----------------------- ----------------- ----------------- -----------------
  Age                \(y\)              34 ± 8                  35 ± 5            35 ± 6            36 ± 6
  Body mass index    (kg/m^2^)          23.84 ± 3.99            24.11 ± 2.22      23.27 ± 3.26      23.55 ± 3.9822
  Vitamin E          μg/ml              11.76 ± 3.17            11.66 ± 3.24      11.66 ± 3.24      11.66 ± 3.98
  α~1~-antitrypsin   g/L serum          1.49 ± 0.32             1.98 ± 0.27\*     1.96 ± 0.39\*     1.94 ± 0.38\*
  CCR                μg/mg creatinine   0.049 ± 0.017           0.268 ± 0.244\*   0.974 ± 0.759\*   1.13 ± 0.56\*
  PHA                SI                 70.54 ± 43.35           47.50 ± 34.63     89.05 ± 61.07     80.93 ± 55.85
  Con A              SI                 54.73 ± 38.35           33.33 ± 17.07     66.94 ± 41.32     57.13 ± 23.01
  White cell count   (a.n. x 10^9^/L)   7.99 ± 1.74             9.83 ± 2.60\*     8.71 ± 2.16       9.55 ± 1.96\*
  Lymphocytes        (a.n. x 10^9^/L)   3.25 ± 0.74             3.77 ± 1.45       3.50 ± 1.00       3.58 ± 1.01
  (%)                41.19 ± 7.76       37.68 ± 7.36            40.61 ± 6.74      39.83 ± 6.77      
  T cell             (a.n. x 10^9^/L)   2.05 ± 0.55             2.39 ± 0.10       2.36 ± 0.68       2.31 ± 0.71
  (%)                62.76 ± 7.54       63.14 ± 11.31           64.64 ± 7.32      64.67 ± 7.83      
  B cell             (a.n. x 10^9^/L)   0.38 ± 0.20             0.67 ± 0.51\*     0.52 ± 0.29\*     0.54 ± 0.17\*
  (%)                11.13 ± 4.09       16.86 ± 6.20\*          14.36 ± 4.20\*    14.80 ± 4.28\*    
  NK cells           (a.n. x 10^9^/L)   0.83 ± 0.35             0.67 ± 0.35       0.66 ± 0.31\*     0.67 ± 0.33
  (%)                25.31 ± 903        19.00 ± 8.25\*          19.34 ± 6.67\*    18.20 ± 7.16\*    
  CD4^+^             (a.n. x 10^9^/L)   0.92 ± 0.28             0.99 ± 0.30       1.18 ± 0.43\*     1.14± 0.26\*
                     (%)                28.27 ± 6.43            27.29 ± 4.42      33.44 ± 5.46      31.47 ± 5.82
  CD8^+^             (a.n. x 10^9^/L)   1.05 ± 0.39             1.17 ± 0.60       1.00 ± 0.34       1.049± 0.42
                     (%)                31.53 ± 7.52            30.00 ± 7.81      28.89 ± 6.92      29.33 ± 7.16
  CD4^+^/CD8^+^      (%)                0.97 ± 0.44             0.987 ± 0.383     1.22 ± 0.37\*     1.16 ± 0.42

S1 refers to \< 9 cigarettes/d, S2; 10-19 cigarettes/d and S3; \>20
cigarettes/d. \* indicates significant difference as compared to
nonsmokers (p \< 0.05).
::::

## Lymphocyte proliferation

There was no difference in the lymphocyte proliferation after induction
with mitogens PHA and Con A between the different groups (smoking vs
nonsmoking) (Table  [3](#)). When the group of smokers divided into the
number of cigarettes smoked per day, it seems to reduce in S1 group and
increased in S2 and S3 group (Table  [2](#)). But it remained unaffected
by palmvitee supplementation (Table  [3](#)). But there seemed to be a
trend for the lymphocyte proliferation to increase at 24 weeks in the
palmvitee-supplemented group induced with PHA (Table  [3](#) &[4](#)).

:::: table-wrap
::: caption
The effects of palmvitee supplementation on lymphocyte proliferative
presented as stimulation index (S.I.) after induction with mitogen, PHA
and Con A in nonsmokers and smokers
:::

  **Weeks**   **Con A (S.I)**                                         
  ----------- ----------------- ------------------- ----------------- -------------------
              **Non-smokers**   **Smokers**                           
              Placebo, n = 27   Palmvitee, n = 29   Placebo, n = 28   Palmvitee, n = 30
  0           49.77 ± 36.42     59.17 ± 40.10       69.21 ± 41.11     52.72 ± 30.00
  12          48.19 ± 28.62     51.03 ± 28.78       47.70 ± 29.73     59.50 ± 34.18
  24          46.92 ± 23.64     55.10 ± 27.23       42.21 ± 26.59     42.93 ± 31.75
              **PHA (S.I)**                                           
  0           66.72 ± 48.82     73.97 ± 38.35       91.96 ± 62.15     73.45 ± 53.44
  12          70.59 ± 39.43     72.14 ± 28.88       65.74 ± 34.69     75.27 ± 35.85
  24          69.15 ± 28.32     86.41 ± 41.53       69.39 ± 38.07     77.10 ± 59.44

Results are shown as mean ± SD.
::::

:::: table-wrap
::: caption
The effects of palmvitee supplementation on lymphocyte proliferative
presented as stimulation index (S.I.) after induction with mitogen, PHA
and Con A in nonsmokers and smokers according to the number of
cigarettes per day
:::

  **Weeks**   **S1**               **S2**                 **S3**                                                            
  ----------- -------------------- ---------------------- --------------------- ---------------------- -------------------- ---------------------
              **Placebo, n = 4**   **Palmvitee, n = 3**   **Placebo, n = 17**   **Palmvitee,n = 19**   **Placebo, n = 7**   **Palmvitee,n = 8**
              **Con A (SI)**                                                                                                
  0           37.75 ± 15.73        24.50 ± 21.92          80.00 ± 48.12         55.26 ± 30.92          61.00 ± 15.41        53.75 ± 39.75
  12          39.25 ± 15.09        55.00 ± 35.59          53.50 ± 35.02         59.32 ± 40.01          39.29 ± 20.77        61.63 ± 28.52\*
  24          36.00 ± 32.65        22.00 ± 24.56          46.24 ± 28.03         49.26 ± 35.55          36.00 ± 20.94        35.75 ± 26.99
              **PHA (SI)**                                                                                                  
  0           58.00 ± 39.30        26.50 ± 6.36           73.17 ± 40.22         70.21 ± 44.99          67.29 ± 29.84        44.60 ± 28.53
  12          60.50 ± 24.96        51.67 ± 30.62          69.44 ± 40.09         76.58 ± 35.20          60.29 ± 28.19        81.00 ± 38.53
  24          59.25 ± 24.07        72.67 ± 69.82          74.71 ± 44.45         78.47 ± 68.50          62.29 ± 27.49        75.50 ± 32.96

Results are shown as means ± SD. \* indicates significant difference as
compared to nonsmokers.
::::

## T-cell subsets and B cell percentage

Table  [5](#) shows the baseline levels of white blood cells counts,
lymphocytes and T-cell subsets in smokers and nonsmokers. Table  [2](#)
shows the baseline according the number of cigarettes smoked per day.
When comparing immune parameters between smokers and nonsmokers, WBC
counts was higher in smokers (n = 58) compared to nonsmokers (n = 56,
p \< 0.01) and unaffected by palmvitee supplementation (Table  [6](#)).
No difference in the total number and percentage of lymphocytes and
CD3^+^ cells was observed before and after palmvitee supplementation
(Table  [6](#)). In separated group; S3, total CD3^+^ cells (T cell)
increased significantly (p \< 0.05) compared to nonsmokers before
supplementation (Table  [2](#)) and remained unchanged in
palmvitee-supplemented group (Table  [7](#)). The percentage of B cells
in smokers was higher compared to nonsmokers (p \< 0.0001) and also in
S1 (p \< 0.005), S2 (p \< 0.0005) and S3 groups (p \< 0.005) (Table 
[2](#)). After palmvitee supplementation, B cells percentage was
significantly increased in nonsmokers at 24 weeks (p \< 0.05) but not in
the smokers (Table  [6](#)). In S1 and S3 palmvitee-supplemented groups
there was a trend of increment in B cells percentage. The increment was
correlated at 12 (r = 0.98, 0.87) and 24 weeks (r = 0.98, 0.96)
respectively.

:::: table-wrap
::: caption
Baseline levels of lymphocytes in smokers and nonsmokers
:::

                                               **Nonsmokers n = 56**   **Smokers n = 58**    
  ------------------------- ------------------ ----------------------- -------------------- ----------------
  Age                       \(y\)              34 ± 8                  36 ± 6               NS
  Body mass index (kg/m2)   (kg/m^2^)          23.84 ± 3.99            23.52 ± 3.42         NS
  Vitamin E                 μg/ml              11.76 ± 3.17            11.66 ± 3.24         NS
  α~1~-antitrypsin          g/L serum          1.49 ± 0.32             1.96 ± 0.37          P \< 0.0000001
  CCR                       μg/mg creatinine   0.049 ± 0.017           0.93 ± 0.31          P \< 0.0000001
  PHA                       SI                 70.54 ± 43.35           77.50 ± 55.34        NS
  Con A                     SI                 54.73 ± 38.35           59.98 ± 36.29        NS
  White cell count          (a.n. x 10^9^/L)   7.99 ± 1.74             9.06 ± 2.18          P \< 0.01
  Lymphocytes               (a.n. x 10^9^/L)   3.25 ± 0.74             3.58 ± 1.01          NS
                            (%)                41.19 ± 7.76            39.83 ± 6.77          
  .                         NS                                                               
  T cell                    (a.n. x 10^9^/L)   2.05 ± 0.55             2.31 ± 0.71          NS
                            (%)                62.76 ± 7.54            64.67 ± 7.83         NS
  B cell                    (a.n. x 10^9^/L)   0.38 ± 0.20             0.54 ± 0.29          P \< 0.00001
                            (%)                11.13 ± 4.09            14.78 ± 4.48         P \< 0.00001
  NK cells                  (a.n. x 10^9^/L)   0.83 ± 0.35             0.66 ± 0.31          P \< 0.001
                            (%)                25.31 ± 903             19.00 ± 6.88         P \< 0.0001
  CD4^+^                    (a.n. x 10^9^/L)   0.92 ± 0.28             1.15± 0.38           P \< 0.0001
                            (%)                28.27 ± 6.43            32.19 ± 5.73         P \< 0.0001
  CD8^+^                    (a.n. x 10^9^/L)   1.05 ± 0.39             1.04 ± 0.39          NS
                            (%)                31.53 ± 7.52            29.14 ± 6.97         NS
  CD4^+^/CD8^+^             (%)                0.97 ± 0.44             1.18 ± 0.38          P \< 0.0001

a.n. represents actual number.
::::

:::: table-wrap
::: caption
**The effects of palmvitee supplementation on total white blood cells,
lymphocytes, CD3**^**+**^**cells, B lymphocyte, in whole blood of
nonsmokers and smokers**
:::

  **Weeks**   **WBC**                               **Lymphocytes**   **CD3+ cells**               **B lymphocyte**                                                
  ----------- ------------------------------------- ----------------- ---------------------------- ------------------ ---------------------------- --------------- ----------------------------
              **a.n. x 10**^**9**^**/L**            **%**             **a.n. x 10**^**9**^**/L**   **%**              **a.n. x 10**^**9**^**/L**   **%**           **a.n. x 10**^**9**^**/L**
              **Non-smokers (placebo, n = 27)**                                                                                                                    
  0           7.62 ± 1.89                           41.96 ± 9.34      3.12 ± 0.77                  63.54 ± 7.03       1.99 ± 0.60                  10.19 ± 4.06    0.35 ± 0.26
  12          7.29 ± 2.10                           42.39 ± 6.12      3.04 ± 0.84                  65.96 ± 6.70       2.00 ± 0.56                  10.89 ± 3.56    0.33 ± 0.14
  24          7.14 ± 1.53                           41.85 ± 8.85      2.94 ± 0.72                  64.27 ± 7.12       1.88 ± 0.50                  11.00 ± 3.88    0.32 ± 0.12
              **Non-smokers (palmvitee, n = 29)**                                                                                                                  
  0           8.32 ± 1.55                           40.52 ± 6.17      3.36 ± 0.70                  62.07 ± 8.02       2.09 ± 0.52                  11.97 ± 4.00    0.40 ± 0.13+
  12          8.27 ± 2.08                           40.39 ± 6.09      3.33 ± 0.74                  62.72 ± 7.60       2.10 ± 0.55                  12.45 ± 4.67    0.41 ± 0.16+
  24          8.02 ± 1.50                           38.05 ± 5.80+     3.05 ± 0.77                  61.66 ± 14.23      1.96 ± 0.55                  13.72 ± 4.53+   0.41 ± 0.15+
              **Smokers (placebo, n = 28)**                                                                                                                        
  0           9.74 ± 2.31                           40.44 ± 7.39      3.91 ± 1.14                  63.50 ± 7.87       2.47 ± 0.71                  15.54 ± 5.06    0.64 ± 0.38
  12          9.38 ± 2.45                           40.53 ± 8.20      3.76 ± 1.16                  63.82 ± 8.34       2.40 ± 0.65                  16.14 ± 4.70    0.59 ± 0.33
  24          8.81 ± 2.30                           38.00 ± 8.68      3.30 ± 1.04                  66.11 ± 10.78      2.14 ± 0.63                  15.25 ± 4.40    0.52 ± 0.29
              **Smokers (palmvitee, n = 30)**                                                                                                                      
  0           8.43 ± 1.86                           39.27 ± 6.20      3.27 ± 0.75                  65.77 ± 7.75       2.16 ± 0.69                  14.06 ± 3.81    0.45 ± 0.15
  12          8.13 ± 2.29                           40.07 ± 7.04      3.19 ± 0.72                  66.27 ± 6.59       2.13 ± 0.58                  14.30 ± 4.09    0.45 ± 0.16
  24          8.06 ± 2.10                           37.68 ± 7.29      3.01 ± 0.88                  66.83 ± 7.28       2.02 ± 0.69                  14.40 ± 4.03    0.43 ± 0.16

Results are shown as mean ± SD. + indicates significant difference as
compared to non-smokers taking placebo (p \< 0.05), a.n. represents
actual number.
::::

:::: table-wrap
::: caption
**The effects of palmvitee supplementation on total white blood cells,
lymphocytes, CD3**^**+**^**cells, B lymphocyte, in whole blood of
nonsmokers and smokers according to the number of cigarettes per day**
:::

  **Weeks**   **WBC**                                          **Lymphocytes**   **CD3**^**+**^**cells**      **B lymphocyte**                                               
  ----------- ------------------------------------------------ ----------------- ---------------------------- ------------------ ---------------------------- -------------- ----------------------------
              **a.n. x 10**^**9**^**/L**                       **%**             **a.n. x 10**^**9**^**/L**   **%**              **a.n. x 10**^**9**^**/L**   **%**          **a.n. x 10**^**9**^**/L**
              **S1; 1-9 cigarettes/d (placebo, n = 4)**                                                                                                                      
  0           9.80 ± 2.07                                      37.25 ± 8.59      3.79 ± 1.65                  59.75 ± 13.25      2.21 ± 0.81                  17.75 ± 8.42   0.76 ± 0.70
  12          10.05 ± 3.10                                     38.63 ± 10.59     3.94 ± 2.08                  58.00 ± 11.58      2.36 ± 0.93                  18.00 ± 6.38   0.81 ± 0.73
  24          9.43 ± 2.67                                      36.05 ± 10.39     3.56 ± 1.92                  54.75 ± 21.93      1.91 ± 0.96                  15.25 ± 6.90   0.63 ± 0.52
              **S1; 1-9 cigarettes/d (palmvitee, n = 3)**                                                                                                                    
  0           9.87 ± 3.72                                      38.27 ± 7.15      3.75 ± 1.52                  67.67 ± 8.14       2.62 ± 1.40                  15.67 ± 2.31   0.56 ± 0.13
  12          6.73 ± 1.10                                      39.57 ± 5.75      2.64 ± 0.35                  69.00 ± 6.08       1.80 ± 0.11                  17.67 ± 4.04   0.48 ± 0.16
  24          6.53 ± 0.76                                      35.20 ± 11.15     2.29 ± 0.70                  65.33 ± 5.77       1.47 ± 0.35                  19.00 ± 2.65   0.45 ± 0.18
              **S2; 10-19 cigarettes/d (placebo, n = 17)**                                                                                                                   
  0           9.31 ± 2.53                                      42.85 ± 6.63      3.96 ± 1.20                  64.24 ± 6.28       2.54 ± 0.76                  14.82 ± 4.25   0.63 ± 0.37
  12          8.92 ± 2.61                                      41.19 ± 7.34      3.62 ± 0.99                  65.71 ± 7.08       2.38 ± 0.62                  15.47 ± 3.68   0.52 ± 0.28
  24          8.22 ± 2.38                                      40.26 ± 8.70      3.23 ± 0.95                  68.12± 7.03        2.18 ± 0.63                  14.82 ± 3.59   0.50 ± 0.2
              **S2; 10-19 cigarettes/d (palmvitee, n = 19)**                                                                                                                 
  0           8.17 ± 1.65                                      38.59 ± 6.35      3.10 ± 0.54                  65.00 ± 8.30       2.00 ± 0.51                  13.95 ± 4.24   0.42 ± 0.14
  12          8.11 ± 2.36                                      38.51 ± 7.34      3.02 ± 0.60                  65.74 ± 7.34       2.01 ± 0.52                  13.63 ± 3.52   0.41 ± 0.14
  24          7.64 ± 2.02                                      37.22 ± 8.70      2.81 ± 0.74                  67.26 ± 7.01       1.89 ± 0.55                  13.37 ± 3.99   0.38 ± 0.15
              **S3; \>20 cigarettes/d (placebo, n = 7)**                                                                                                                     
  0           10.76 ± 1.75                                     36.42 ± 7.01      3.87 ± 0.81                  63.86 ± 8.65       2.46 ± 0.58                  16.00 ± 5.16   0.60 ± 0.17
  12          10.11 ± 1.58                                     39.99 ± 9.93      3.99 ± 1.10                  62.57 ± 8.83       2.49 ± 0.68                  16.71 ± 6.26   0.64 ± 0.23
  24          9.90 ± 1.58                                      33.66 ± 6.62      3.31 ± 0.77                  67.71± 7.09        2.18 ± 0.44                  16.29 ± 5.22   0.50 ± 0.18
              **S3; \>20 cigarettes/d (palmvitee, n = 8)**                                                                                                                   
  0           8.50 ± 1.54                                      41.23 ± 6.12      3.50 ± 0.70                  66.88 ± 7.95       2.37 ± 0.51                  13.75 ± 3.97   0.48 ± 0.13
  12          8.70 ± 2.06                                      43.96 ± 6.03      3.79 ± 0.74                  66.50 ± 7.53       2.55 ± 0.55                  14.63 ± 4.63   0.55 ± 0.16
  24          9.64 ± 1.49                                      39.71 ± 5.75      3.75 ± 0.76                  66.38 ± 14.10      2.54 ± 0.54                  15.13 ± 4.49   0.56 ± 0.15

Results are shown as mean ± SD.
::::

The percentage of NK cells were lower in smokers compared to nonsmokers
(p \< 0.0001) at baseline (S1: p \< 0.05, S2: p \< 0.005, S3: p \< 0.01)
and after palmvitee supplementation (Table  [8](#) and Table  [9](#)).
CD4^+^ in nonsmokers were lower than smokers at the beginning of the
study (p \< 0.0001). Total CD4^+^ in smokers were increased according to
number of cigarettes per day. CD8^+^ percentage did not show any
significant difference among the groups. CD4^+^/CD8^+^ ratio was found
to be significantly increased (p \< 0.001) in smokers compared to
nonsmokers at baseline (Table  [5](#)) and also in S2. However, no
significant changes were observed after palmvitee supplementation for
both smokers and nonsmokers (Table  [9](#)). There were also no changes
observed in these parameters at the different times of supplementation.

:::: table-wrap
::: caption
**The effects of vitamin E supplementation on NK cells,
CD4**^**+**^**cells, CD8**^**+**^**cells and
CD4**^**+**^**/CD8**^**+**^**in whole blood of nonsmokers and smokers**
:::

  **Weeks**   **NK cells**                          **CD4**^**+**^         **CD8**^**+**^   **CD4**^**+**^**/CD8**^**+**^                                          
  ----------- ------------------------------------- ---------------------- ---------------- ------------------------------- --------------- ---------------------- ---------------
              **%**                                 **a.n. x 10**^**9**^   **%**            **a.n. x 10**^**9**^            **%**           **a.n. x 10**^**9**^   **%**
              **Non-smokers (placebo, n = 27)**                                                                                                                    
  0           25.00 ± 9.44                          0.73 ± 0.34            29.07 ± 6.16     0.91 ± 0.28                     31.69 ± 7.41    0.99 ± 0.41            0.99 ± 0.40
  12          22.85 ± 7.74                          0.70 ± 0.35            30.81 ± 6.75     0.94 ± 0.35                     31.19 ± 8.03    1.00 ± 0.36            1.02 ± 0.46
  24          24.72 ± 7.94                          0.75 ± 0.32            31.27 ± 6.87     0.92 ± 0.32                     32.07 ± 8.30    0.94 ± 0.36            1.07 ± 0.48
              **Non-smokers (palmvitee, n = 29)**                                                                                                                  
  0           25.59 ± 8.80                          0.86 ± 0.36            27.55 ± 6.68     0.92 ± 0.29                     31.38 ± 7.75    1.07 ± 0.30            0.96 ± 0.48
  12          24.59 ± 8.45                          0.81 ± 0.33            27.62 ± 7.72     0.92 ± 0.33                     30.28 ± 6.75    1.03 ± 0.35            0.97 ± 0.47
  24          24.72 ± 8.78                          0.72 ± 0.42            30.17 ± 9.35     0.90 ± 0.30                     31.00 ± 6.72    0.96 ± 0.37            1.03 ± 0.53
              **Smokers (placebo, n = 28)**                                                                                                                        
  0           19.54 ± 7.50+                         0.76 ± 0.39            32.18 ± 5.98+    1.24 ± 0.44+                    27.82 ± 5.36+   1.08 ± 0.34            1.22 ± 0.38+
  12          19.46 ± 8.55+                         0.75 ± 0.45            33.07 ± 7.32+    1.23 ± 0.39+                    27.46 ± 6.01+   1.05 ± 0.36            1.24 ± 0.40+
  24          19.18 ± 10.93+                        0.64 ± 0.46            35.14 ± 7.93+    1.14 ± 0.44+                    28.04 ± 7.34    0.93 ± 0.27            1.25 ± 0.36+
              **Smokers (palmvitee, n = 30)**                                                                                                                      
  0           18.48 ± 6.32++                        0.58 ± 0.17++          32.20 ± 5.54++   1.03 ± 0.29                     30.37 ± 8.09    1.00 ± 0.45            1.13 ± 0.39
  12          17.87 ± 6.50++                        0.55 ± 0.21++          33.20 ± 5.56++   1.07 ± 0.29++                   30.17 ± 8.21    0.98 ± 0.42            1.21 ± 0.44++
  24          19.03 ± 7.82                          0.57 ± 0.27            33.90 ± 5.56++   1.03 ± 0.37                     30.67 ± 7.61    0.92 ± 0.38            1.19 ± 0.43++

Results are shown as mean ± SD. a.n. represents actual number. +
indicates significant difference as compared to nonsmokers taking
placebo (p \< 0.05). ++ indicates significant difference as compared to
nonsmokers taking palmvitee (p \< 0.05).
::::

:::: table-wrap
::: caption
**The effects of vitamin E supplementation on NK cells,
CD4**^**+**^**cells, CD8**^**+**^**cells and
CD4**^**+**^**/CD8**^**+**^**in whole blood of nonsmokers and smokers
according to the number of cigarettes per day**
:::

  **Weeks**   **NK cells**                                     **CD4**^**+**^         **CD8**^**+**^   **CD4**^**+**^**/CD8**^**+**^                                          
  ----------- ------------------------------------------------ ---------------------- ---------------- ------------------------------- --------------- ---------------------- -------------
              **%**                                            **a.n. x 10**^**9**^   **%**            **a.n. x 10**^**9**^            **%**           **a.n. x 10**^**9**^   **%**
              **S1; 1-9 cigarettes/d (placebo, n = 4)**                                                                                                                       
  0           21.50 ± 9.57                                     0.78 ± 0.45            26.25 ± 5.44     0.93 ± 0.22                     28.25 ± 9.11    1.09 ± 0.51            1.05 ± 0.50
  12          22.00 ± 12.73                                    0.87 ± 0.65            25.25 ± 3.20     0.96 ± 0.41                     27.25 ± 9.25    1.07 ± 0.55            1.02 ± 0.43
  24          31.75 ± 22.78                                    1.09 ± 0.97            23.75 ± 7.27     0.83 ± 0.40                     25.50 ± 11.85   0.87 ± 0.42            0.99 ± 0.22
              **S1; 1-9 cigarettes/d (palmvitee, n = 3)**                                                                                                                     
  0           15.67 ± 6.11                                     0.53 ± 0.04            28.67 ± 3.06     1.07 ± 0.43                     32.33 ± 6.66    1.28 ± 0.79            0.90 ± 0.20
  12          13.67 ± 1.53                                     0.37 ± 0.09            34.67 ± 2.08     0.92 ± 0.16                     30.67 ± 4.73    0.79 ± 0.46            1.16 ± 0.23
  24          18.33 ± 6.43                                     0.45 ± 0.25            29.67 ± 3.79     0.69 ± 0.26                     31.00 ± 6.24    0.68 ± 0.10            0.99 ± 0.29
              **S2; 10-19 cigarettes/d (placebo, n = 17)**                                                                                                                    
  0           19.59 ± 6.75                                     0.76 ± 0.38            34.18 ± 6.15     1.37 ± 0.52                     27.76 ± 4.83    1.07 ± 0.32            1.30 ± 0.39
  12          20.12 ± 8.37                                     0.71 ± 0.39            35.65 ± 7.55     1.29 ± 0.41                     27.24 ± 5.84    1.01 ± 0.29            1.33 ± 0.40
  24          17.47 ± 6.69                                     0.55 ± 0.25            37.06 ± 7.04     1.21 ± 0.49                     28.94 ± 7.26    0.93 ± 0.25            1.31 ± 0.38
              **S2; 10-19 cigarettes/d (palmvitee, n = 19)**                                                                                                                  
  0           19.11 ± 6.78                                     0.57 ± 0.20            32.79 ± 4.85     1.02 ± 0.26                     29.89 ± 8.38    0.93 ± 0.35            1.15 ± 0.34
  12          18.42 ± 7.27                                     0.53 ± 0.20            33.05 ±5.78      1.01 ± 0.26                     30.05 ± 7.71    0.93 ± 0.33            1.20 ± 0.45
  24          18.58 ± 7.88                                     0.52 ± 0.26            34.95 ± 5.02     0.99 ± 0.34                     30.74 ± 7.26    0.85 ± 0.28            1.23 ± 0.47
              **S3; \>20 cigarettes/d (placebo, n = 7)**                                                                                                                      
  0           18.29 ± 9.01                                     0.74 ± 0.47            30.71 ± 2.81     1.18 ± 0.21                     27.71 ± 5.06    1.08 ± 0.35            1.15 ± 0.30
  12          18.43 ± 7.46                                     0.76 ± 0.52            31.29 ± 4.57     1.21 ± 0.27                     28.14 ± 5.30    1.13 ± 0.42            1.14 ± 0.38
  24          16.14 ± 5.84                                     0.61 ± 0.39            37.00 ± 4.86     1.15 ± 0.25                     27.29 ± 4.96    1.01 ± 0.45            1.24 ± 0.37
              **S3; \>20 cigarettes/d (palmvitee, n = 8)**                                                                                                                    
  0           18.13 ± 8.72                                     0.60 ± 0.36            32.13 ± 6.63     1.09 ± 0.29                     30.75 ± 7.68    1.09 ± 0.37            1.17 ± 0.48
  12          18.13 ± 8.37                                     0.67 ± 0.32            33.00 ± 7.65     1.24 ± 0.33                     30.25 ± 6.69    1.17 ± 0.35            1.25 ± 0.46
  24          20.38 ± 8.70                                     0.73 ± 0.42            33.00 ± 9.27     1.24 ± 0.29                     30.38 ± 6.66    1.17 ± 0.37            1.19 ± 0.15

Results are shown as mean ± SD.
::::

A significant positive correlation was observed in smokers when
comparing total white blood cells count and total B cells count at
0 week (r = 0.57, p \< 0.05) (Table  [2](#)). Also a significant
positive correlation was found between TWBC count and total CD4^+^ cell
count before starting supplementation (r = 0.59, p \< 0.05).
